InvestSMART
  1. Home
  2. Research & Advice
  3. Research Tools
  4. Shares
  5. Global X S&P Biotech ETF (CURE)
  6. Company Announcements

Global X S&P Biotech ETF (ASX: CURE) - Announcements

Current share price for CURE : $50.500 0.56 (1.12%)+

Global X S&P Biotech ETF (CURE) is an Exchange Traded Fund - commonly known as an ETF. For more details about how ETFs work, feel free to check out our What is an ETF? overview. Global X S&P Biotech ETF (CURE, formerly ETFS S&P Biotech ETF) is an exchange traded fund that provides exposure to U.S. healthcare biotechnology companies. These companies are engaged in the research, development and manufacturing of products based on genetic analysis and genetic engineering.

Latest company announcements for Global X S&P Biotech ETF (CURE)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$38 ETFS Units on Issue November 2020 1 Dec 2020 9:45AM $67.540 $50.500 fallen by 25.23%
$38 ETFS Units on Issue October 2020 6 Nov 2020 5:35PM $63.520 $50.500 fallen by 20.50%
$38 ETFS Units on Issue September 2020 1 Oct 2020 6:44PM $59.300 $50.500 fallen by 14.84%
$38 CURE Annual Financial Report 24 Sep 2020 8:15AM $59.850 $50.500 fallen by 15.62%
$38 ETFS Units on Issue - August 2020 1 Sep 2020 8:50AM $56.640 $50.500 fallen by 10.84%
$38 ETFS Units on Issue - July 2020 3 Aug 2020 10:47AM $58.400 $50.500 fallen by 13.53%
$38 Update - Dividend/Distribution - CURE 1 Jul 2020 4:48PM $61.500 $50.500 fallen by 17.89%
$38 ETFS Units on Issue - June 2020 1 Jul 2020 8:18AM $61.200 $50.500 fallen by 17.48%
$38 Update - Dividend/Distribution - CURE 29 Jun 2020 12:06PM $68.240 $50.500 fallen by 26%
$38 Dividend/Distribution - CURE 24 Jun 2020 5:56PM $69.470 $50.500 fallen by 27.31%
$38 ETFS Units on Issue - May 2020 1 Jun 2020 9:46AM $65.200 $50.500 fallen by 22.55%
$38 ETFS Units on Issue - April 2020 1 May 2020 10:30AM $58.970 $50.500 fallen by 14.36%
$38 ETFS Units on Issue - March 2020 2 Apr 2020 8:55AM $52.530 $50.500 fallen by 3.86%
$38 CURE Half Yearly Report and Accounts 11 Mar 2020 6:12PM $53.150 $50.500 fallen by 4.99%
$38 ETFS Units on Issue - February 2020 2 Mar 2020 3:24PM $58.060 $50.500 fallen by 13.02%
$38 Product Disclosure Statement Dated 11th February 2020 2 Mar 2020 9:00AM $55.180 $50.500 fallen by 8.48%
$38 ETFS Units on Issue - January 2020 6 Feb 2020 9:34AM $58.040 $50.500 fallen by 12.99%
$38 ETFS Units on Issue - December 2019 3 Jan 2020 12:13PM $58.130 $50.500 fallen by 13.13%
$38 ETFS Units on Issue - November 2019 3 Dec 2019 9:22AM $58.510 $50.500 fallen by 13.69%
$38 ETFS Units on Issue - October 2019 4 Nov 2019 9:39AM $49.940 $50.500 risen by 1.12%
$38 ETFS Units on Issue - September 2019 1 Oct 2019 3:06PM $48.150 $50.500 risen by 4.88%

76 - 96 of 96 results

Page 4 of 4

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.